Abstract
Traditionally, histopathological evaluations of tissue sections are performed for the diagnosis and grading of cancers using subjective appraisal of the tissue and cell phenotypes. In the last decade, a combination of unprecedented advances in imaging and computing technologies and novel machine learning-based algorithms has driven the field of histopathology into a new dimension. Machine learning and deep learning methodologies applied on digitalized hematoxylin and eosin stained tissue sections have out-performed conventional methods to accurately identify cancer cells or classify tumors into prognostic groups. Nevertheless, we believe that a precise, standardized measurement of nuclear morphology and chromatin texture based on a DNA stain can further improve the diagnosis of cancers and identify patients with high-risk of recurrence, alone or in combination with other clinical, pathological or molecular information. Changes in the morphology of cell nuclei and tissue architecture are intrinsic characteristics and hallmarks of cancer. Nuclei from cancerous samples exhibit different morphological and chromatin texture than nuclei from normal cells, thus, reflecting the structural and molecular effects of genetic and epigenetic alterations driving cancer processes. By image analysis, the chromatin texture can be measured in high-resolution breaking down the components of the nuclear changes into multiple quantifiable units that can be studied independently and in combination using advanced machine learning methods. This allows the investigator to examine associations of such changes with cancer progression and clinical outcomes. There is now increasing interest in developing new algorithms and platforms to decipher spatial relationship between cell subpopulations in whole tissue sections.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Zink, D., Fischer, A.H., Nickerson, J.A.: Nuclear structure in cancer cells. Nat. Rev. Cancer 4(9), 677–687 (2004)
Singh, H., Sekinger, E.A., Gross, D.S.: Chromatin and cancer: causes and consequences. J. Cell. Biochem. 79(Suppl. 35), 61–68 (2000)
Almassalha, L.M., Tiwari, A., Ruhoff, P.T., et al.: The global relationship between chromatin physical topology, fractal structure, and gene expression. Sci. Rep. 7, 41061 (2017)
Hveem, T.S., Njolstad, T.S., Nielsen, B., et al.: Changes in chromatin structure in curettage specimens identifies high-risk patients in endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 26(1), 61–67 (2017)
O’Connor, J.P., Aboagye, E.O., Adams, J.E., et al.: Imaging biomarker roadmap for cancer studies. Nat. Rev. Clin. Oncol. 14(3), 169–186 (2016)
Beck, A.H., Sangoi, A.R., Leung, S., et al.: Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci. Transl. Med. 3(108), 108ra113 (2011)
Mukhopadhyay, S., Feldman, M.D., Abels, E., et al.: Whole slide imaging versus microscopy for primary diagnosis in surgical pathology: a multicenter blinded randomized noninferiority study of 1992 cases (pivotal study). Am. J. Surg. Pathol. 42(1), 39–52 (2018)
Tizhoosh, H.R., Pantanowitz, L.: Artificial intelligence and digital pathology: challenges and opportunities. J. Pathol. Inform. 9, 38 (2018)
Bychkov, D., Linder, N., Turkki, R., et al.: Deep learning based tissue analysis predicts outcome in colorectal cancer. Sci. Rep. 8(1), 3395 (2018)
Biesterfeld, S., Beckers, S., Del Carmen Villa Cadenas, M., et al.: Feulgen staining remains the gold standard for precise DNA image cytometry. Anticancer Res. 31(1), 53–58 (2011)
Ghizoni, J.S., Sperandio, M., Lock, C., et al.: Image cytometry DNA ploidy analysis: correlation between two semi-automated methods. Oral Dis. 24(7), 1204–1208 (2018)
Guillaud, M., Zhang, L., Poh, C., et al.: Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res. 68(9), 3099–3107 (2008). PMID: 18451134
El Hallani, S., Guillaud, M., Korbelik, J., et al.: Evaluation of quantitative digital pathology in the assessment of barrett esophagus-associated dysplasia. Am. J. Clin. Pathol. 144(1), 151–164 (2015)
Guillaud, M., Ye, Q., Leung, S., Carraro, A., et al.: Large-scale DNA organization is a prognostic marker of breast cancer survival. Med. Oncol. 35(1), 9 (2017)
MacAulay, C., Keyes, M., Hayes, M., et al.: Quantification of large scale DNA organization for predicting prostate cancer recurrence. Cytometry A 91(12), 1164–1174 (2017)
Holzinger, A., Haibe-Kains, B., Jurisica, I.: Why imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data. Eur. J. Nucl. Med. Mol. Imaging 46(13), 2722–2730 (2019)
Jean-Quartier, C., Jeanquartier, F., Jurisica, I., Holzinger, A.: In silico cancer research towards 3R. BMC Cancer 18(1), 408 (2018)
O’Sullivan, S., Holzinger, A., Zatloukal, K., et al.: Machine learning enhanced virtual autopsy. Autops Case Rep. 7(4), 3–7 (2017)
Chatelain, R., Willms, A., Biesterfeld, S., et al.: Automated Feulgen staining with a temperature controlled machine. Anal. Quant. Cytol. Histol. 11, 211–217 (1989)
Haroske, G., Baak, J.P., Danielsen, H., et al.: Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal. Cell. Pathol. 23(2), 89–95 (2001)
Doudkine, A., Macaulay, C., Poulin, N., et al.: Nuclear texture measurements in image cytometry. Pathologica 87(3), 286–299 (1995)
Bahr, G.F., Bartels, P.H., Bibbo, M., et al.: Evaluation of the Papanicolaou stain for computer-assisted cellular pattern recognition. Acta Cytol. 17, 106–112 (1973)
Schulte, E.K.W., Fink, D.K.: Hematoxylin staining in quantitative DNA cytometry: an image analysis study. Anal. Cell. Pathol. 9, 257–268 (1995)
Liu, S., Semenciw, R., Probert, A., et al.: Cervical cancer in Canada: changing patterns in incidence and mortality. Int. J. Gynecol. Cancer 11, 24–31 (2001)
Guidozzi, F.: Screening for cervical cancer. Obstet. Gynecol. Surv. 51, 247–252 (1996)
McCord, M.L., Stovall, T.G., Meric, J.L., et al.: Cervical cytology: a randomized comparison of four sampling methods. Am. J. Obstet. Cynecol. 166, 1772–1779 (1992)
Stenkvist, B., Soderstrom, J.: Reasons for cervical cancer despite extensive screening. J. Med. Screen. 3, 204–207 (1996)
Wilbur, D.C., Cibas, E.S., Merritt, S., et al.: ThinPrep processor: clinic trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am. J. Clin. Pathol. 101, 209–214 (1994)
Guillaud, M., Benedet, J.L., Cantor, S.B., et al.: DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation. Cancer 107(2), 309–318 (2006)
Sun, X.R., Wang, J., Garner, D., et al.: Detection of cervical cancer and high grade neoplastic lesions by a combination of liquid-based sampling preparation and DNA measurements using automated image cytometry. Cell Oncol. 27(1), 33–41 (2005)
Xu, S., Mei, J.H., Han, Y.L., et al.: Quantitative analysis of cervical cell DNA and liquid-based cytology in cervical screening of early lesions comparison. Guangdong Yixue 34, 1387–1390 (2013)
Tian, Y.W., Liu, G., Zhou, J., et al.: Application of DNA image cytometry in the cervical intraepithelial neoplasia and cervical cancer screening. Zhenduan Binglixue Zazhi 20, 425–428 (2013)
Wei, L.F., Lin, H.M., Qin, Y.A.F.: Clinical research of cervical cell DNA quantitative analysis in opportunistic screening of cervical diseases among women in cities of Zhuang national minority regions. Huaxia Yixue 25, 181–184 (2012)
Motic Regulatory. http://www.med.motic.com/Page.aspx?PageCategoryId=7&PageContentId=4&LangCode=zhcn
Landing Med Regulatory. http://landingmed.com/cn/
Reid, B.J., Haggitt, R.C., Rubin, C.E., et al.: Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum. Pathol. 19, 166–178 (1988)
Montgomery, E., Bronner, M.P., Goldblum, J.R., et al.: Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum. Pathol. 32, 368–378 (2001)
Glazer, E.S., Bartels, P.H., Prasad, A.R., et al.: Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma. Cancer Prev. Res. (Phila) 4, 1770–1777 (2011)
Nielsen, B., Albregtsen, F., Kildal, W., et al.: The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer. Anal. Cell. Pathol. (Amst) 35, 305–314 (2012)
Veltri, R.W., Khan, M.A., Miller, M.C., et al.: Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate. Clin. Cancer Res. 10, 3465–3473 (2004)
Guillaud, M., Zhang, L., Poh, C., et al.: Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res. 68, 3099–3107 (2008)
Guillaud, M., le Riche, J.C., Dawe, C., et al.: Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: correlation with genetic damage and cancer development. Cytometry A 63, 34–40 (2005)
Swartz, R., West, L., Boiko, I., et al.: Use of nuclear morphometry characteristics to distinguish between normal and abnormal cervical glandular histologies. Anal. Cell. Pathol. 25, 193–200 (2003)
Poulin, N., Frost, A., Carraro, A., et al.: Risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry. Anal. Cell. Pathol. 25, 129–138 (2003)
Paik, S., Tang, G., Shak, S., et al.: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J. Clin. Oncol. 24(23), 3726–3734 (2006)
Harris, L.N., Ismaila, N., McShane, L.M., et al.: Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: american society of clinical oncology clinical practice guideline. J. Clin. Oncol. 34(10), 1134–1150 (2016)
Poulin, N., Susnik, B., Guillaud, M., et al.: Histometric texture analysis of DNA in thin sections from breast biopsies. Application to the detection of malignancy-associated changes in carcinoma in situ. Anal. Quant. Cytol. Histol. 17(5), 291–299 (1995)
Susnik, B., Worth, A., Palcic, B., et al.: Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast. Anal. Cell. Pathol. 8(1), 39–52 (1995)
Grimm, P., Billiet, I., Bostwick, D., et al.: Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 109, 22–29 (2012)
Enfield, K.S.S., Martin, S.D., Marshall, E.A., et al.: Hyperspectral cell sociology reveals spatial tumor immune cell interactions associated with lung cancer recurrence. J. Immunother. Cancer 7(1), 13 (2019)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
El Hallani, S., MacAulay, C., Guillaud, M. (2020). Digital Image Analysis in Pathology Using DNA Stain: Contributions in Cancer Diagnostics and Development of Prognostic and Theranostic Biomarkers. In: Holzinger, A., Goebel, R., Mengel, M., Müller, H. (eds) Artificial Intelligence and Machine Learning for Digital Pathology. Lecture Notes in Computer Science(), vol 12090. Springer, Cham. https://doi.org/10.1007/978-3-030-50402-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-50402-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50401-4
Online ISBN: 978-3-030-50402-1
eBook Packages: Computer ScienceComputer Science (R0)